BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Stoller JK, Aboussouan LS. Alpha1-antitrypsin deficiency. Lancet. 2005;365:2225-2236. [PMID: 15978931 DOI: 10.1016/s0140-6736(05)66781-5] [Cited by in Crossref: 386] [Cited by in F6Publishing: 124] [Article Influence: 22.7] [Reference Citation Analysis]
Number Citing Articles
1 Szalontai K, Gémes N, Furák J, Varga T, Neuperger P, Balog JÁ, Puskás LG, Szebeni GJ. Chronic Obstructive Pulmonary Disease: Epidemiology, Biomarkers, and Paving the Way to Lung Cancer. J Clin Med 2021;10:2889. [PMID: 34209651 DOI: 10.3390/jcm10132889] [Reference Citation Analysis]
2 Jonigk D, Al-Omari M, Maegel L, Müller M, Izykowski N, Hong J, Hong K, Kim SH, Dorsch M, Mahadeva R. Anti-inflammatory and immunomodulatory properties of α1-antitrypsin without inhibition of elastase. Proc Natl Acad Sci USA. 2013;110:15007-15012. [PMID: 23975926 DOI: 10.1073/pnas.1309648110] [Cited by in Crossref: 149] [Cited by in F6Publishing: 139] [Article Influence: 16.6] [Reference Citation Analysis]
3 Djekic UV, Gaggar A, Weathington NM. Attacking the multi-tiered proteolytic pathology of COPD: new insights from basic and translational studies. Pharmacol Ther 2009;121:132-46. [PMID: 19026684 DOI: 10.1016/j.pharmthera.2008.09.008] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 2.0] [Reference Citation Analysis]
4 Chino K, Ganzberg S, Mendoza K. Office-Based Sedation/General Anesthesia for COPD Patients, Part II. Anesth Prog 2019;66:44-51. [PMID: 30883229 DOI: 10.2344/anpr-66-02-05] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
5 Guan Q, Tian Y, Zhang Z, Zhang L, Zhao P, Li J. Identification of Potential Key Genes in the Pathogenesis of Chronic Obstructive Pulmonary Disease Through Bioinformatics Analysis. Front Genet 2021;12:754569. [PMID: 34804123 DOI: 10.3389/fgene.2021.754569] [Reference Citation Analysis]
6 Ferrarotti I, Poplawska-Wisniewska B, Trevisan MT, Koepke J, Dresel M, Koczulla R, Ottaviani S, Baldo R, Gorrini M, Sala G, Cavallon L, Welte T, Chorostowska-Wynimko J, Luisetti M, Janciauskiene S. How Can We Improve the Detection of Alpha1-Antitrypsin Deficiency? PLoS One 2015;10:e0135316. [PMID: 26270547 DOI: 10.1371/journal.pone.0135316] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
7 Zheng J, Garg S, Wang J, Loose DS, Hauer-Jensen M. Laser capture microdissected mucosa versus whole tissue specimens for assessment of radiation-induced dynamic molecular and pathway changes in the small intestine. PLoS One 2013;8:e53711. [PMID: 23341980 DOI: 10.1371/journal.pone.0053711] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
8 Hull S, Mathur R, Lloyd-Owen S, Round T, Robson J. Improving outcomes for people with COPD by developing networks of general practices: evaluation of a quality improvement project in east London. NPJ Prim Care Respir Med 2014;24:14082. [PMID: 25322204 DOI: 10.1038/npjpcrm.2014.82] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
9 Kessenbrock K, Fröhlich L, Sixt M, Lämmermann T, Pfister H, Bateman A, Belaaouaj A, Ring J, Ollert M, Fässler R, Jenne DE. Proteinase 3 and neutrophil elastase enhance inflammation in mice by inactivating antiinflammatory progranulin. J Clin Invest 2008;118:2438-47. [PMID: 18568075 DOI: 10.1172/JCI34694] [Cited by in Crossref: 59] [Cited by in F6Publishing: 162] [Article Influence: 4.2] [Reference Citation Analysis]
10 Gold M, Dolga AM, Koepke J, Mengel D, Culmsee C, Dodel R, Koczulla AR, Bach JP. α1-antitrypsin modulates microglial-mediated neuroinflammation and protects microglial cells from amyloid-β-induced toxicity. J Neuroinflammation 2014;11:165. [PMID: 25245568 DOI: 10.1186/s12974-014-0165-8] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 3.3] [Reference Citation Analysis]
11 Summer R, Little FF, Ouchi N, Takemura Y, Aprahamian T, Dwyer D, Fitzsimmons K, Suki B, Parameswaran H, Fine A, Walsh K. Alveolar macrophage activation and an emphysema-like phenotype in adiponectin-deficient mice. Am J Physiol Lung Cell Mol Physiol 2008;294:L1035-42. [PMID: 18326826 DOI: 10.1152/ajplung.00397.2007] [Cited by in Crossref: 88] [Cited by in F6Publishing: 91] [Article Influence: 6.3] [Reference Citation Analysis]
12 Guo S, Booten SL, Watt A, Alvarado L, Freier SM, Teckman JH, McCaleb ML, Monia BP. Using antisense technology to develop a novel therapy for α-1 antitrypsin deficient (AATD) liver disease and to model AATD lung disease. Rare Dis 2014;2:e28511. [PMID: 25054094 DOI: 10.4161/rdis.28511] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
13 Jackson PL, Xu X, Wilson L, Weathington NM, Clancy JP, Blalock JE, Gaggar A. Human neutrophil elastase-mediated cleavage sites of MMP-9 and TIMP-1: implications to cystic fibrosis proteolytic dysfunction. Mol Med. 2010;16:159-166. [PMID: 20111696 DOI: 10.2119/molmed.2009.00109] [Cited by in Crossref: 58] [Cited by in F6Publishing: 64] [Article Influence: 4.8] [Reference Citation Analysis]
14 Köhnlein T, Rifai K. [Alpha1-antitrypsin deficiency]. Internist (Berl) 2010;51 Suppl 1:269-76. [PMID: 20135085 DOI: 10.1007/s00108-009-2505-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
15 Karadagi A, Cavedon AG, Zemack H, Nowak G, Eybye ME, Zhu X, Guadagnin E, White RA, Rice LM, Frassetto AL, Strom S, Jorns C, Martini PGV, Ellis E. Systemic modified messenger RNA for replacement therapy in alpha 1-antitrypsin deficiency. Sci Rep 2020;10:7052. [PMID: 32341402 DOI: 10.1038/s41598-020-64017-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
16 Zhang X, Shan P, Jiang G, Cohn L, Lee PJ. Toll-like receptor 4 deficiency causes pulmonary emphysema. J Clin Invest 2006;116:3050-9. [PMID: 17053835 DOI: 10.1172/JCI28139] [Cited by in Crossref: 163] [Cited by in F6Publishing: 101] [Article Influence: 10.2] [Reference Citation Analysis]
17 Ortega VE, Li X, O'Neal WK, Lackey L, Ampleford E, Hawkins GA, Grayeski PJ, Laederach A, Barjaktarevic I, Barr RG, Cooper C, Couper D, Han MK, Kanner RE, Kleerup EC, Martinez FJ, Paine R 3rd, Peters SP, Pirozzi C, Rennard SI, Woodruff PG, Hoffman EA, Meyers DA, Bleecker ER; NHLBI Subpopulations and Intermediate Outcomes Measures in COPD Study (SPIROMICS). The Effects of Rare SERPINA1 Variants on Lung Function and Emphysema in SPIROMICS. Am J Respir Crit Care Med 2020;201:540-54. [PMID: 31661293 DOI: 10.1164/rccm.201904-0769OC] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
18 Nader CP, Cidem A, Verrills NM, Ammit AJ. Protein phosphatase 2A (PP2A): a key phosphatase in the progression of chronic obstructive pulmonary disease (COPD) to lung cancer. Respir Res 2019;20:222. [PMID: 31623614 DOI: 10.1186/s12931-019-1192-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
19 Wang C, Zhou J, Wang J, Li S, Fukunaga A, Yodoi J, Tian H. Progress in the mechanism and targeted drug therapy for COPD. Signal Transduct Target Ther 2020;5:248. [PMID: 33110061 DOI: 10.1038/s41392-020-00345-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
20 Donato LJ, Karras RM, Katzmann JA, Murray DL, Snyder MR. Quantitation of circulating wild-type alpha-1-antitrypsin in heterozygous carriers of the S and Z deficiency alleles. Respir Res 2015;16:96. [PMID: 26243289 DOI: 10.1186/s12931-015-0256-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
21 Koulmanda M, Bhasin M, Hoffman L, Fan Z, Qipo A, Shi H, Bonner-Weir S, Putheti P, Degauque N, Libermann TA, Auchincloss H Jr, Flier JS, Strom TB. Curative and beta cell regenerative effects of alpha1-antitrypsin treatment in autoimmune diabetic NOD mice. Proc Natl Acad Sci U S A 2008;105:16242-7. [PMID: 18852471 DOI: 10.1073/pnas.0808031105] [Cited by in Crossref: 126] [Cited by in F6Publishing: 117] [Article Influence: 9.0] [Reference Citation Analysis]
22 Campos MA, Runken MC, Davis AM, Johnson MP, Stone GA, Buikema AR. Impact of a Health Management Program on Healthcare Outcomes among Patients on Augmentation Therapy for Alpha 1-Antitrypsin Deficiency: An Insurance Claims Analysis. Adv Ther 2018;35:467-81. [PMID: 29616482 DOI: 10.1007/s12325-018-0690-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
23 Tabara Y, Setoh K, Kawaguchi T, Kosugi S, Nakayama T, Matsuda F. Association between serum α1-antitrypsin levels and all-cause mortality in the general population: the Nagahama study. Sci Rep 2021;11:17241. [PMID: 34446826 DOI: 10.1038/s41598-021-96833-3] [Reference Citation Analysis]
24 Abboud RT, Nelson TN, Jung B, Mattman A. Alpha1-antitrypsin deficiency: a clinical-genetic overview. Appl Clin Genet 2011;4:55-65. [PMID: 23776367 DOI: 10.2147/TACG.S10604] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
25 Liu H, Ma L, Wu J, Wang K, Chen X. Apoptosis of alveolar wall cells in chronic obstructive pulmonary disease patients with pulmonary emphysema is involved in emphysematous changes. J Huazhong Univ Sci Technolog Med Sci 2009;29:466-9. [PMID: 19662364 DOI: 10.1007/s11596-009-0415-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
26 Minai OA, Benditt J, Martinez FJ. Natural history of emphysema. Proc Am Thorac Soc 2008;5:468-74. [PMID: 18453357 DOI: 10.1513/pats.200802-018ET] [Cited by in Crossref: 24] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
27 Cummings EE, O'Reilly LP, King DE, Silverman RM, Miedel MT, Luke CJ, Perlmutter DH, Silverman GA, Pak SC. Deficient and Null Variants of SERPINA1 Are Proteotoxic in a Caenorhabditis elegans Model of α1-Antitrypsin Deficiency. PLoS One 2015;10:e0141542. [PMID: 26512890 DOI: 10.1371/journal.pone.0141542] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
28 Mwirigi NW, Thomas CF. Hypersensitivity vasculitis with leukocytoclastic vasculitis associated with alpha-1-proteinase inhibitor. Case Rep Med 2009;2009:941258. [PMID: 20204065 DOI: 10.1155/2009/941258] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
29 Veith M, Klemmer A, Anton I, El Hamss R, Rapun N, Janciauskiene S, Kotke V, Herr C, Bals R, Vogelmeier CF, Greulich T. Diagnosing Alpha-1-Antitrypsin Deficiency Using A PCR/Luminescence-Based Technology. Int J Chron Obstruct Pulmon Dis 2019;14:2535-42. [PMID: 31819391 DOI: 10.2147/COPD.S224221] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
30 Stapels DAC, Woehl JL, Milder FJ, Tromp AT, van Batenburg AA, de Graaf WC, Broll SC, White NM, Rooijakkers SHM, Geisbrecht BV. Evidence for multiple modes of neutrophil serine protease recognition by the EAP family of Staphylococcal innate immune evasion proteins. Protein Sci 2018;27:509-22. [PMID: 29114958 DOI: 10.1002/pro.3342] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
31 Kim DY, Kim WJ, Kim JH, Hong SH, Choi SS. Identification of Putative Regulatory Alterations Leading to Changes in Gene Expression in Chronic Obstructive Pulmonary Disease. Mol Cells 2019;42:333-44. [PMID: 31085807 DOI: 10.14348/molcells.2019.2442] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
32 Lomas DA. New Therapeutic Targets for Alpha-1 Antitrypsin Deficiency. Chronic Obstr Pulm Dis 2018;5:233-43. [PMID: 30723781 DOI: 10.15326/jcopdf.5.4.2017.0165] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
33 Lee JS. Heterogeneity of lung mononuclear phagocytes in chronic obstructive pulmonary disease. J Innate Immun 2012;4:489-97. [PMID: 22572241 DOI: 10.1159/000337434] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
34 Wang C, Zhao P, Sun S, Teckman J, Balch WE. Leveraging Population Genomics for Individualized Correction of the Hallmarks of Alpha-1 Antitrypsin Deficiency. Chronic Obstr Pulm Dis 2020;7:224-46. [PMID: 32726074 DOI: 10.15326/jcopdf.7.3.2019.0167] [Reference Citation Analysis]
35 Zhumagaliyeva A, Ottaviani S, Greulich T, Gorrini M, Vogelmeier C, Karazhanova L, Nurgazina G, DeSilvestri A, Kotke V, Barzon V, Zorzetto M, Corsico A, Ferrarotti I. Case-finding for alpha1-antitrypsin deficiency in Kazakh patients with COPD. Multidiscip Respir Med 2017;12:23. [PMID: 29090095 DOI: 10.1186/s40248-017-0104-5] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
36 Martin C, Frija J, Burgel PR. Dysfunctional lung anatomy and small airways degeneration in COPD. Int J Chron Obstruct Pulmon Dis 2013;8:7-13. [PMID: 23319856 DOI: 10.2147/COPD.S28290] [Cited by in Crossref: 3] [Cited by in F6Publishing: 10] [Article Influence: 0.3] [Reference Citation Analysis]
37 Luna Diaz LV, Iupe I, Zavala B, Balestrini KC, Guerrero A, Holt G, Calderon-Candelario R, Mirsaeidi M, Campos M. Improving adherence to alpha-1 antitrypsin deficiency screening guidelines using the pulmonary function laboratory. Int J Chron Obstruct Pulmon Dis 2017;12:2257-9. [PMID: 28814853 DOI: 10.2147/COPD.S143424] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
38 Fowell AJ, Fancey K, Gamble K, Bicknell K, Dowman JK, Howden P, Aspinall RJ. Evaluation of a primary to secondary care referral pathway and novel nurse-led one-stop clinic for patients with suspected non-alcoholic fatty liver disease. Frontline Gastroenterol 2021;12:102-7. [PMID: 33613940 DOI: 10.1136/flgastro-2019-101304] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
39 Rao SR, Sundararajan S, Subbarayan R, Murugan Girija D. Cyclosporine-A induces endoplasmic reticulum stress and influences pro-apoptotic factors in human gingival fibroblasts. Mol Cell Biochem 2017;429:179-85. [PMID: 28324237 DOI: 10.1007/s11010-017-2945-9] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
40 Malik AT, Jain N, Kim J, Khan SN, Yu E. Chronic Obstructive Pulmonary Disease Is an Independent Predictor for 30-Day Complications and Readmissions Following 1- to 2-Level Anterior Cervical Discectomy and Fusion. Global Spine J 2019;9:298-302. [PMID: 31192098 DOI: 10.1177/2192568218794170] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
41 Bazett M, Biala A, Huff RD, Zeglinksi MR, Hansbro PM, Bosiljcic M, Gunn H, Kalyan S, Hirota JA. Attenuating immune pathology using a microbial-based intervention in a mouse model of cigarette smoke-induced lung inflammation. Respir Res 2017;18:92. [PMID: 28506308 DOI: 10.1186/s12931-017-0577-y] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
42 Faffe DS, Zin WA. Lung parenchymal mechanics in health and disease. Physiol Rev 2009;89:759-75. [PMID: 19584312 DOI: 10.1152/physrev.00019.2007] [Cited by in Crossref: 110] [Cited by in F6Publishing: 91] [Article Influence: 8.5] [Reference Citation Analysis]
43 Hawkins P, Sya J, Hup NK, Murphy MP, McElvaney NG, Reeves EP. Alpha-1 Antitrypsin Augmentation Inhibits Proteolysis of Neutrophil Membrane Voltage-Gated Proton Channel-1 in Alpha-1 Deficient Individuals. Medicina (Kaunas) 2021;57:814. [PMID: 34441020 DOI: 10.3390/medicina57080814] [Reference Citation Analysis]
44 Zhou Y, Zhang Y. Serine protease acylation proceeds with a subtle re-orientation of the histidine ring at the tetrahedral intermediate. Chem Commun (Camb) 2011;47:1577-9. [PMID: 21116528 DOI: 10.1039/c0cc04112b] [Cited by in Crossref: 35] [Cited by in F6Publishing: 12] [Article Influence: 2.9] [Reference Citation Analysis]
45 Ghosh A, Boucher RC, Tarran R. Airway hydration and COPD. Cell Mol Life Sci 2015;72:3637-52. [PMID: 26068443 DOI: 10.1007/s00018-015-1946-7] [Cited by in Crossref: 43] [Cited by in F6Publishing: 42] [Article Influence: 6.1] [Reference Citation Analysis]
46 Huch M, Gehart H, van Boxtel R, Hamer K, Blokzijl F, Verstegen MM, Ellis E, van Wenum M, Fuchs SA, de Ligt J, van de Wetering M, Sasaki N, Boers SJ, Kemperman H, de Jonge J, Ijzermans JN, Nieuwenhuis EE, Hoekstra R, Strom S, Vries RR, van der Laan LJ, Cuppen E, Clevers H. Long-term culture of genome-stable bipotent stem cells from adult human liver. Cell. 2015;160:299-312. [PMID: 25533785 DOI: 10.1016/j.cell.2014.11.050] [Cited by in Crossref: 709] [Cited by in F6Publishing: 645] [Article Influence: 88.6] [Reference Citation Analysis]
47 Chang YP, Mahadeva R, Chang WW, Lin SC, Chu YH. Small-molecule peptides inhibit Z alpha1-antitrypsin polymerization. J Cell Mol Med 2009;13:2304-16. [PMID: 19120695 DOI: 10.1111/j.1582-4934.2008.00608.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 2.4] [Reference Citation Analysis]
48 Serban KA, Petrache I. Alpha-1 Antitrypsin and Lung Cell Apoptosis. Ann Am Thorac Soc 2016;13 Suppl 2:S146-9. [PMID: 27115949 DOI: 10.1513/AnnalsATS.201505-312KV] [Cited by in F6Publishing: 11] [Reference Citation Analysis]
49 Castaldi PJ, Cho MH, Cohn M, Langerman F, Moran S, Tarragona N, Moukhachen H, Venugopal R, Hasimja D, Kao E, Wallace B, Hersh CP, Bagade S, Bertram L, Silverman EK, Trikalinos TA. The COPD genetic association compendium: a comprehensive online database of COPD genetic associations. Hum Mol Genet 2010;19:526-34. [PMID: 19933216 DOI: 10.1093/hmg/ddp519] [Cited by in Crossref: 84] [Cited by in F6Publishing: 79] [Article Influence: 6.5] [Reference Citation Analysis]
50 Miniati M, Bottai M, Pavlickova I, Monti S. Body height as risk factor for emphysema in COPD. Sci Rep 2016;6:36896. [PMID: 27874046 DOI: 10.1038/srep36896] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
51 Potočnjak I, Tešović G, Kuna AT, Stefanović M, Zaja O. Unusually difficult clinical presentation of an infant suffering from congenital Cytomegalovirus (CMV) infection combined with alpha 1-antitrypsin (A1AT) deficiency. Biochem Med (Zagreb) 2014;24:396-402. [PMID: 25351359 DOI: 10.11613/BM.2014.043] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
52 Sieluk J, Slejko JF, Silverman H, Perfetto E, Mullins CD. Medical costs of Alpha-1 antitrypsin deficiency-associated COPD in the United States. Orphanet J Rare Dis 2020;15:260. [PMID: 32967697 DOI: 10.1186/s13023-020-01523-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
53 Sandhaus R, Strange C, Stone G, Runken MC, Blanchette CM, Howden R. Comorbidity Associations with AATD Among Commercially Insured and Medicare Beneficiaries with COPD in the US. Int J Chron Obstruct Pulmon Dis 2020;15:2389-97. [PMID: 33116454 DOI: 10.2147/COPD.S263297] [Reference Citation Analysis]
54 Kim M, Cai Q, Oh Y. Therapeutic potential of alpha-1 antitrypsin in human disease. Ann Pediatr Endocrinol Metab 2018;23:131-5. [PMID: 30286568 DOI: 10.6065/apem.2018.23.3.131] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
55 Rigobello C, Baraldo S, Tinè M, Ferrarotti I, Corsico AG, Bazzan E, Turato G, Balestro E, Biondini D, Valle G, Saetta M, Cosio MG. Exome Sequencing Reveals Immune Genes as Susceptibility Modifiers in Individuals with α1-Antitrypsin Deficiency. Sci Rep 2019;9:13088. [PMID: 31511551 DOI: 10.1038/s41598-019-49409-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
56 Krawczyk M, Müllenbach R, Weber SN, Zimmer V, Lammert F. Genome-wide association studies and genetic risk assessment of liver diseases. Nat Rev Gastroenterol Hepatol. 2010;7:669-681. [PMID: 21045792 DOI: 10.1038/nrgastro.2010.170] [Cited by in Crossref: 46] [Cited by in F6Publishing: 44] [Article Influence: 3.8] [Reference Citation Analysis]
57 Rögnvaldsson T, Etchells TA, You L, Garwicz D, Jarman I, Lisboa PJ. How to find simple and accurate rules for viral protease cleavage specificities. BMC Bioinformatics 2009;10:149. [PMID: 19445713 DOI: 10.1186/1471-2105-10-149] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
58 Miglino N, Roth M, Tamm M, Borger P. Asthma and COPD - The C/EBP Connection. Open Respir Med J 2012;6:1-13. [PMID: 22715349 DOI: 10.2174/1874306401206010001] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
59 Chotirmall SH, Al-Alawi M, McEnery T, McElvaney NG. Alpha-1 proteinase inhibitors for the treatment of alpha-1 antitrypsin deficiency: safety, tolerability, and patient outcomes. Ther Clin Risk Manag 2015;11:143-51. [PMID: 25673994 DOI: 10.2147/TCRM.S51474] [Cited by in Crossref: 16] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
60 Ghosh AJ, Hobbs BD. Recent advancements in understanding the genetic involvement of alpha-1 antitrypsin deficiency associated lung disease: a look at future precision medicine approaches. Expert Rev Respir Med 2022;:1-10. [PMID: 35025710 DOI: 10.1080/17476348.2022.2027755] [Reference Citation Analysis]
61 Felisbino MB, Fernandes FLA, Nucci MCNM, Pinto RMC, Pizzichini E, Cukier A. The patient profile of individuals with Alpha-1 antitrypsine gene mutations at a referral center in Brazil. J Bras Pneumol 2018;44:383-9. [PMID: 30517339 DOI: 10.1590/S1806-37562017000000420] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
62 Hoàng TH, Phạm TN, Nguyễn GK, Lê QH. A rare variant of α 1 antitrypsin mutations detected in Vietnamese children with liver disease. Ann Clin Biochem 2013;50:339-44. [PMID: 23766346 DOI: 10.1177/0004563212473443] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
63 Zhou JJ, Cho MH, Castaldi PJ, Hersh CP, Silverman EK, Laird NM. Heritability of chronic obstructive pulmonary disease and related phenotypes in smokers. Am J Respir Crit Care Med 2013;188:941-7. [PMID: 23972146 DOI: 10.1164/rccm.201302-0263OC] [Cited by in Crossref: 75] [Cited by in F6Publishing: 48] [Article Influence: 8.3] [Reference Citation Analysis]
64 Pirozzi C, Scholand MB. Smoking cessation and environmental hygiene. Med Clin North Am 2012;96:849-67. [PMID: 22793948 DOI: 10.1016/j.mcna.2012.04.014] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
65 Milstein S, Qian K, Zhang L, Sehgal A. Methods to Identify and Characterize siRNAs Targeting Serpin A1 In Vitro and In Vivo Using RNA Interference. Methods Mol Biol 2017;1639:115-26. [PMID: 28752451 DOI: 10.1007/978-1-4939-7163-3_11] [Reference Citation Analysis]
66 Ghio AJ, Soukup JM, Richards JH, Fischer BM, Voynow JA, Schmechel DE. Deficiency of α-1-antitrypsin influences systemic iron homeostasis. Int J Chron Obstruct Pulmon Dis 2013;8:45-51. [PMID: 23378755 DOI: 10.2147/COPD.S37897] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
67 Hennawy MG, Elhosseiny NM, Sultan H, Abdelfattah W, Akl Y, Sabry NA, Attia AS. The effect of α1-antitrypsin deficiency combined with increased bacterial loads on chronic obstructive pulmonary disease pharmacotherapy: A prospective, parallel, controlled pilot study. J Adv Res 2016;7:1019-28. [PMID: 27857848 DOI: 10.1016/j.jare.2016.05.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
68 McGrady T, Mannino DM, Malanga E, Thomashow BM, Walsh J, Sandhaus RA, Stoller JK. Characteristics of Chronic Obstructive Pulmonary Disease (COPD) Patients Reporting Alpha-1 Antitrypsin Deficiency in the WebMD Lung Health Check Database. Chronic Obstr Pulm Dis 2015;2:141-51. [PMID: 28848838 DOI: 10.15326/jcopdf.2.2.2015.0160] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
69 Sandström CS, Novoradovskaya N, Cilio CM, Piitulainen E, Sveger T, Janciauskiene S. Endotoxin receptor CD14 in PiZ alpha-1-antitrypsin deficiency individuals. Respir Res 2008;9:34. [PMID: 18426570 DOI: 10.1186/1465-9921-9-34] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
70 Demkow U, van Overveld FJ. Role of elastases in the pathogenesis of chronic obstructive pulmonary disease: implications for treatment. Eur J Med Res 2010;15 Suppl 2:27-35. [PMID: 21147616 DOI: 10.1186/2047-783x-15-s2-27] [Cited by in Crossref: 23] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
71 Kass I, Knaupp AS, Bottomley SP, Buckle AM. Conformational properties of the disease-causing Z variant of α1-antitrypsin revealed by theory and experiment. Biophys J 2012;102:2856-65. [PMID: 22735536 DOI: 10.1016/j.bpj.2012.05.023] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 2.2] [Reference Citation Analysis]
72 Yin HL, Yin SQ, Lin QY, Xu Y, Xu HW, Liu T. Prevalence of comorbidities in chronic obstructive pulmonary disease patients: A meta-analysis. Medicine (Baltimore) 2017;96:e6836. [PMID: 28489768 DOI: 10.1097/MD.0000000000006836] [Cited by in Crossref: 48] [Cited by in F6Publishing: 25] [Article Influence: 9.6] [Reference Citation Analysis]
73 Tanjore H, Lawson WE, Blackwell TS. Endoplasmic reticulum stress as a pro-fibrotic stimulus. Biochim Biophys Acta. 2013;1832:940-947. [PMID: 23201247 DOI: 10.1016/j.bbadis.2012.11.011] [Cited by in Crossref: 80] [Cited by in F6Publishing: 80] [Article Influence: 8.0] [Reference Citation Analysis]
74 Mosheimer B, Alzner R, Wiedermann CJ. Immunomodulation by alpha(1)-proteinase inhibitor: lack of chemotactic effects of recombinant human alpha(1)-proteinase inhibitor from yeast on human peripheral blood granulocytes. Arch Immunol Ther Exp (Warsz) 2007;55:399-403. [PMID: 18060368 DOI: 10.1007/s00005-007-0045-3] [Reference Citation Analysis]
75 Henrot P, Prevel R, Berger P, Dupin I. Chemokines in COPD: From Implication to Therapeutic Use. Int J Mol Sci 2019;20:E2785. [PMID: 31174392 DOI: 10.3390/ijms20112785] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 7.0] [Reference Citation Analysis]
76 Guihard PJ, Yao J, Blazquez-Medela AM, Iruela-Arispe L, Boström KI, Yao Y. Endothelial-Mesenchymal Transition in Vascular Calcification of Ins2Akita/+ Mice. PLoS One 2016;11:e0167936. [PMID: 27936229 DOI: 10.1371/journal.pone.0167936] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
77 Kessenbrock K, Dau T, Jenne DE. Tailor-made inflammation: how neutrophil serine proteases modulate the inflammatory response. J Mol Med (Berl) 2011;89:23-8. [PMID: 20809089 DOI: 10.1007/s00109-010-0677-3] [Cited by in Crossref: 66] [Cited by in F6Publishing: 60] [Article Influence: 5.5] [Reference Citation Analysis]
78 Wu LJ, Chen ZY, Wang Y, Zhao JG, Xie XZ, Chen G. Organoids of liver diseases: From bench to bedside. World J Gastroenterol 2019; 25(16): 1913-1927 [PMID: 31086460 DOI: 10.3748/wjg.v25.i16.1913] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
79 Klemmer A, Greulich T, Koczulla A, Vogelmeier C. Die chronisch-obstruktive Lungenerkrankung (COPD): Aktuelle Konzepte und neue Therapieoptionen. Internist 2014;55:401-14. [DOI: 10.1007/s00108-013-3406-5] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
80 Russo R, Zillmer LR, Nascimento OA, Manzano B, Ivanaga IT, Fritscher L, Lundgren F, Miravitlles M, Gondim HD, Santos G Junior, Alves MA, Oliveira MV, Souza AA, Sales MP, Jardim JR. Prevalence of alpha-1 antitrypsin deficiency and allele frequency in patients with COPD in Brazil. J Bras Pneumol 2016;42:311-6. [PMID: 27812629 DOI: 10.1590/S1806-37562015000000180] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
81 Sarabhai T, Peter C, Bär AK, Windolf J, Relja B, Wesselborg S, Wahlers T, Paunel-Görgülü A. Serum α-1 Antitrypsin (AAT) antagonizes intrinsic apoptosis induction in neutrophils from patients with systemic inflammatory response syndrome. PLoS One 2017;12:e0177450. [PMID: 28493974 DOI: 10.1371/journal.pone.0177450] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
82 Yang C, Keshavjee S, Liu M. Alpha-1 Antitrypsin for COVID-19 Treatment: Dual Role in Antiviral Infection and Anti-Inflammation. Front Pharmacol 2020;11:615398. [PMID: 33362565 DOI: 10.3389/fphar.2020.615398] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
83 Nyfeler B, Reiterer V, Wendeler MW, Stefan E, Zhang B, Michnick SW, Hauri HP. Identification of ERGIC-53 as an intracellular transport receptor of alpha1-antitrypsin. J Cell Biol 2008;180:705-12. [PMID: 18283111 DOI: 10.1083/jcb.200709100] [Cited by in Crossref: 90] [Cited by in F6Publishing: 76] [Article Influence: 6.4] [Reference Citation Analysis]
84 Brown BN, Price IM, Toapanta FR, DeAlmeida DR, Wiley CA, Ross TM, Oury TD, Vodovotz Y. An agent-based model of inflammation and fibrosis following particulate exposure in the lung. Math Biosci 2011;231:186-96. [PMID: 21385589 DOI: 10.1016/j.mbs.2011.03.005] [Cited by in Crossref: 44] [Cited by in F6Publishing: 37] [Article Influence: 4.0] [Reference Citation Analysis]
85 Petrache I, Fijalkowska I, Medler TR, Skirball J, Cruz P, Zhen L, Petrache HI, Flotte TR, Tuder RM. alpha-1 antitrypsin inhibits caspase-3 activity, preventing lung endothelial cell apoptosis. Am J Pathol 2006;169:1155-66. [PMID: 17003475 DOI: 10.2353/ajpath.2006.060058] [Cited by in Crossref: 189] [Cited by in F6Publishing: 190] [Article Influence: 11.8] [Reference Citation Analysis]
86 Castaldi PJ, DeMeo DL, Kent DM, Campbell EJ, Barker AF, Brantly ML, Eden E, McElvaney NG, Rennard SI, Stocks JM, Stoller JK, Strange C, Turino G, Sandhaus RA, Griffith JL, Silverman EK. Development of predictive models for airflow obstruction in alpha-1-antitrypsin deficiency. Am J Epidemiol 2009;170:1005-13. [PMID: 19726494 DOI: 10.1093/aje/kwp216] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
87 Fieldes M, Bourguignon C, Assou S, Nasri A, Fort A, Vachier I, De Vos J, Ahmed E, Bourdin A. Targeted therapy in eosinophilic chronic obstructive pulmonary disease. ERJ Open Res 2021;7:00437-2020. [PMID: 33855061 DOI: 10.1183/23120541.00437-2020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
88 McGrady T, Mannino DM, Malanga E, Thomashow BM, Walsh J, Sandhaus RA, Stoller JK. Characteristics of Chronic Obstructive Pulmonary Disease (COPD) Patients Reporting Alpha-1 Antitrypsin Deficiency in the WebMD Lung Health Check Database. Chronic Obstr Pulm Dis 2015;2:141-51. [PMID: 28848838 DOI: 10.15326/jcopdf.2.2.2015.0160] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
89 Yao J, Guihard PJ, Blazquez-Medela AM, Guo Y, Moon JH, Jumabay M, Boström KI, Yao Y. Serine Protease Activation Essential for Endothelial-Mesenchymal Transition in Vascular Calcification. Circ Res 2015;117:758-69. [PMID: 26265629 DOI: 10.1161/CIRCRESAHA.115.306751] [Cited by in Crossref: 55] [Cited by in F6Publishing: 39] [Article Influence: 7.9] [Reference Citation Analysis]
90 O'Donoghue AJ, Jin Y, Knudsen GM, Perera NC, Jenne DE, Murphy JE, Craik CS, Hermiston TW. Global substrate profiling of proteases in human neutrophil extracellular traps reveals consensus motif predominantly contributed by elastase. PLoS One. 2013;8:e75141. [PMID: 24073241 DOI: 10.1371/journal.pone.0075141] [Cited by in Crossref: 78] [Cited by in F6Publishing: 79] [Article Influence: 8.7] [Reference Citation Analysis]
91 Foil KE. Variants of SERPINA1 and the increasing complexity of testing for alpha-1 antitrypsin deficiency. Ther Adv Chronic Dis 2021;12_suppl:20406223211015954. [PMID: 34408833 DOI: 10.1177/20406223211015954] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
92 Craig TJ, Henao MP. Advances in managing COPD related to α1 -antitrypsin deficiency: An under-recognized genetic disorder. Allergy 2018;73:2110-21. [PMID: 29984428 DOI: 10.1111/all.13558] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
93 Kim S, Kim H, Cho N, Lee SK, Han BG, Sull JW, Jee SH, Shin C. Identification of FAM13A gene associated with the ratio of FEV1 to FVC in Korean population by genome-wide association studies including gene-environment interactions. J Hum Genet 2015;60:139-45. [PMID: 25608829 DOI: 10.1038/jhg.2014.118] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
94 Kukkonen MK, Tiili E, Hämäläinen S, Vehmas T, Oksa P, Piirilä P, Hirvonen A. SERPINE2 haplotype as a risk factor for panlobular type of emphysema. BMC Med Genet 2011;12:157. [PMID: 22145704 DOI: 10.1186/1471-2350-12-157] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
95 Teirilä L, Karvala K, Ahonen N, Riska H, Pietinalho A, Tuominen P, Piirilä P, Puustinen A, Wolff H. Proteomic changes of alveolar lining fluid in illnesses associated with exposure to inhaled non-infectious microbial particles. PLoS One 2014;9:e102624. [PMID: 25033447 DOI: 10.1371/journal.pone.0102624] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
96 Zhang J, Summah H, Zhu YG, Qu JM. Nicotinic acetylcholine receptor variants associated with susceptibility to chronic obstructive pulmonary disease: a meta-analysis. Respir Res 2011;12:158. [PMID: 22176972 DOI: 10.1186/1465-9921-12-158] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 1.5] [Reference Citation Analysis]
97 Fra AM, Gooptu B, Ferrarotti I, Miranda E, Scabini R, Ronzoni R, Benini F, Corda L, Medicina D, Luisetti M, Schiaffonati L. Three new alpha1-antitrypsin deficiency variants help to define a C-terminal region regulating conformational change and polymerization. PLoS One 2012;7:e38405. [PMID: 22723858 DOI: 10.1371/journal.pone.0038405] [Cited by in Crossref: 35] [Cited by in F6Publishing: 26] [Article Influence: 3.5] [Reference Citation Analysis]
98 Trapnell BC, Luisetti M. The parallel lives of alpha1-antitrypsin deficiency and pulmonary alveolar proteinosis. Orphanet J Rare Dis 2013;8:153. [PMID: 24079310 DOI: 10.1186/1750-1172-8-153] [Reference Citation Analysis]
99 Magenau JM, Goldstein SC, Peltier D, Soiffer RJ, Braun T, Pawarode A, Riwes MM, Kennel M, Antin JH, Cutler CS, Ho VT, Alyea EP 3rd, Parkin BL, Yanik GA, Choi SW, Lewis EC, Dinarello CA, Koreth J, Reddy P. α1-Antitrypsin infusion for treatment of steroid-resistant acute graft-versus-host disease. Blood 2018;131:1372-9. [PMID: 29437593 DOI: 10.1182/blood-2017-11-815746] [Cited by in Crossref: 50] [Cited by in F6Publishing: 42] [Article Influence: 12.5] [Reference Citation Analysis]
100 Mahr AD, Edberg JC, Stone JH, Hoffman GS, St Clair EW, Specks U, Dellaripa PF, Seo P, Spiera RF, Rouhani FN, Brantly ML, Merkel PA. Alpha₁-antitrypsin deficiency-related alleles Z and S and the risk of Wegener's granulomatosis. Arthritis Rheum 2010;62:3760-7. [PMID: 20827781 DOI: 10.1002/art.27742] [Cited by in Crossref: 64] [Cited by in F6Publishing: 52] [Article Influence: 5.8] [Reference Citation Analysis]
101 Fujii W, Kapellos TS, Baßler K, Händler K, Holsten L, Knoll R, Warnat-Herresthal S, Oestreich M, Hinkley ER, Hasenauer J, Pizarro C, Thiele C, Aschenbrenner AC, Ulas T, Skowasch D, Schultze JL. Alveolar macrophage transcriptomic profiling in COPD shows major lipid metabolism changes. ERJ Open Res 2021;7:00915-2020. [PMID: 34527724 DOI: 10.1183/23120541.00915-2020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
102 Pirooznia N, Hasannia S, Arab SS, Lotfi AS, Ghanei M, Shali A. The design of a new truncated and engineered alpha1-antitrypsin based on theoretical studies: an antiprotease therapeutics for pulmonary diseases. Theor Biol Med Model 2013;10:36. [PMID: 23705923 DOI: 10.1186/1742-4682-10-36] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
103 Benarafa C, Priebe GP, Remold-O'Donnell E. The neutrophil serine protease inhibitor serpinb1 preserves lung defense functions in Pseudomonas aeruginosa infection. J Exp Med 2007;204:1901-9. [PMID: 17664292 DOI: 10.1084/jem.20070494] [Cited by in Crossref: 83] [Cited by in F6Publishing: 86] [Article Influence: 5.5] [Reference Citation Analysis]
104 Li Y, Krowka MJ, Qi Y, Katzmann JA, Song Y, Li Y, Mandrekar SJ, Yang P. Alpha1-antitrypsin deficiency carriers, serum alpha 1-antitrypsin concentration, and non-small cell lung cancer survival. J Thorac Oncol 2011;6:291-5. [PMID: 21173712 DOI: 10.1097/JTO.0b013e31820213fb] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
105 Abdool-Gaffar MS, Calligaro G, Wong ML, Smith C, Lalloo UG, Koegelenberg CFN, Dheda K, Allwood BW, Goolam-Mahomed A, van Zyl-Smit RN. Management of chronic obstructive pulmonary disease-A position statement of the South African Thoracic Society: 2019 update. J Thorac Dis 2019;11:4408-27. [PMID: 31903229 DOI: 10.21037/jtd.2019.10.65] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
106 Patel AR, Patel AR, Singh S, Singh S, Khawaja I. Global Initiative for Chronic Obstructive Lung Disease: The Changes Made. Cureus 2019;11:e4985. [PMID: 31453045 DOI: 10.7759/cureus.4985] [Cited by in Crossref: 12] [Cited by in F6Publishing: 23] [Article Influence: 4.0] [Reference Citation Analysis]
107 Sharafkhaneh A, Hanania NA, Kim V. Pathogenesis of emphysema: from the bench to the bedside. Proc Am Thorac Soc. 2008;5:475-477. [PMID: 18453358 DOI: 10.1513/pats.200708-126et] [Cited by in Crossref: 109] [Cited by in F6Publishing: 62] [Article Influence: 7.8] [Reference Citation Analysis]
108 Chino K, Ganzberg S, Mendoza K. Office-Based Sedation/General Anesthesia for COPD Patients, Part I. Anesth Prog 2018;65:261-8. [PMID: 30715953 DOI: 10.2344/anpr-65-04-12] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
109 Aljarallah B, Ali A, Dowaidar M, Settin A. Prevalence of α-1-antitrypsin gene mutations in Saudi Arabia. Saudi J Gastroenterol 2011;17:256-60. [PMID: 21727732 DOI: 10.4103/1319-3767.82580] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
110 Kok KF, te Morsche RH, van Oijen MG, Drenth JP. Prevalence of genetic polymorphisms in the promoter region of the alpha-1 antitrypsin (SERPINA1) gene in chronic liver disease: a case control study. BMC Gastroenterol 2010;10:22. [PMID: 20170533 DOI: 10.1186/1471-230X-10-22] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
111 Raherison C. Epidémiologie de la bronchopneumopathie chronique obstructive. La Presse Médicale 2009;38:400-5. [DOI: 10.1016/j.lpm.2008.12.015] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
112 Liu F, Zou Y, Huang Q, Zheng L, Wang W. Electronic health records and improved nursing management of chronic obstructive pulmonary disease. Patient Prefer Adherence 2015;9:495-500. [PMID: 25848228 DOI: 10.2147/PPA.S76562] [Cited by in Crossref: 3] [Article Influence: 0.4] [Reference Citation Analysis]
113 Chang YH, Lee SH, Liao IC, Huang SH, Cheng HC, Liao PC. Secretomic analysis identifies alpha-1 antitrypsin (A1AT) as a required protein in cancer cell migration, invasion, and pericellular fibronectin assembly for facilitating lung colonization of lung adenocarcinoma cells. Mol Cell Proteomics 2012;11:1320-39. [PMID: 22896658 DOI: 10.1074/mcp.M112.017384] [Cited by in Crossref: 47] [Cited by in F6Publishing: 27] [Article Influence: 4.7] [Reference Citation Analysis]
114 Bari E, Ferrarotti I, Di Silvestre D, Grisoli P, Barzon V, Balderacchi A, Torre ML, Rossi R, Mauri P, Corsico AG, Perteghella S. Adipose Mesenchymal Extracellular Vesicles as Alpha-1-Antitrypsin Physiological Delivery Systems for Lung Regeneration. Cells 2019;8:E965. [PMID: 31450843 DOI: 10.3390/cells8090965] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 10.0] [Reference Citation Analysis]
115 Meyer M, Jaspers I. Respiratory protease/antiprotease balance determines susceptibility to viral infection and can be modified by nutritional antioxidants. Am J Physiol Lung Cell Mol Physiol 2015;308:L1189-201. [PMID: 25888573 DOI: 10.1152/ajplung.00028.2015] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 4.3] [Reference Citation Analysis]
116 Bashir A, Hazari YM, Bashir S, Hilal N, Banday M, Iqbal MK, Jan TR, Farooq SS, Shah NN, Fazili KM. SERPINA1 Hepatocyte-Specific Promoter Polymorphism Associate with Chronic Obstructive Pulmonary Disease in a Study of Kashmiri Ancestry Individuals. Lung 2018;196:447-54. [PMID: 29804144 DOI: 10.1007/s00408-018-0124-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
117 Khan JH, Lababidi HM, Al-Moamary MS, Zeitouni MO, Al-Jahdali HH, Al-Amoudi OS, Wali SO, Idrees MM, Al-Shimemri AA, Al Ghobain MO, Alorainy HS, Al-Hajjaj MS. The Saudi Guidelines for the Diagnosis and Management of COPD. Ann Thorac Med 2014;9:55-76. [PMID: 24791168 DOI: 10.4103/1817-1737.128843] [Cited by in Crossref: 13] [Cited by in F6Publishing: 23] [Article Influence: 1.6] [Reference Citation Analysis]
118 Wozniak J, Wandtke T, Kopinski P, Chorostowska-Wynimko J. Challenges and Prospects for Alpha-1 Antitrypsin Deficiency Gene Therapy. Hum Gene Ther 2015;26:709-18. [PMID: 26413996 DOI: 10.1089/hum.2015.044] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.9] [Reference Citation Analysis]
119 Blanco I, Lara B, de Serres F. Efficacy of alpha1-antitrypsin augmentation therapy in conditions other than pulmonary emphysema. Orphanet J Rare Dis 2011;6:14. [PMID: 21486454 DOI: 10.1186/1750-1172-6-14] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 3.4] [Reference Citation Analysis]
120 Lee SW, Jung DJ, Jeong GS. Gaining New Biological and Therapeutic Applications into the Liver with 3D In Vitro Liver Models. Tissue Eng Regen Med 2020;17:731-45. [PMID: 32207030 DOI: 10.1007/s13770-020-00245-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
121 Belmonte I, Barrecheguren M, López-Martínez RM, Esquinas C, Rodríguez E, Miravitlles M, Rodríguez-Frías F. Application of a diagnostic algorithm for the rare deficient variant Mmalton of alpha-1-antitrypsin deficiency: a new approach. Int J Chron Obstruct Pulmon Dis 2016;11:2535-41. [PMID: 27877030 DOI: 10.2147/COPD.S115940] [Cited by in Crossref: 9] [Article Influence: 1.5] [Reference Citation Analysis]
122 Zillmer LR, Russo R, Manzano BM, Ivanaga I, Nascimento OA, Souza AA, Santos G Jr, Rodriguez F, Miravitlles M, Jardim JR. Validation and development of an immunonephelometric assay for the determination of alpha-1 antitrypsin levels in dried blood spots from patients with COPD. J Bras Pneumol 2013;39:547-54. [PMID: 24310627 DOI: 10.1590/S1806-37132013000500004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
123 Tuder RM, Janciauskiene SM, Petrache I. Lung disease associated with alpha1-antitrypsin deficiency. Proc Am Thorac Soc 2010;7:381-6. [PMID: 21030517 DOI: 10.1513/pats.201002-020AW] [Cited by in Crossref: 37] [Cited by in F6Publishing: 20] [Article Influence: 3.4] [Reference Citation Analysis]
124 Antuni JD, Barnes PJ. Evaluation of Individuals at Risk for COPD: Beyond the Scope of the Global Initiative for Chronic Obstructive Lung Disease. Chronic Obstr Pulm Dis 2016;3:653-67. [PMID: 28848890 DOI: 10.15326/jcopdf.3.3.2016.0129] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
125 Matsubara J, Ono M, Honda K, Negishi A, Ueno H, Okusaka T, Furuse J, Furuta K, Sugiyama E, Saito Y, Kaniwa N, Sawada J, Shoji A, Sakuma T, Chiba T, Saijo N, Hirohashi S, Yamada T. Survival prediction for pancreatic cancer patients receiving gemcitabine treatment. Mol Cell Proteomics 2010;9:695-704. [PMID: 20061307 DOI: 10.1074/mcp.M900234-MCP200] [Cited by in Crossref: 24] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
126 Sieluk J, Levy J, Sandhaus RA, Silverman H, Holm KE, Mullins CD. Costs of Medical Care Among Augmentation Therapy Users and Non-Users with Alpha-1 Antitrypsin Deficiency in the United States. Chronic Obstr Pulm Dis 2018;6:6-16. [PMID: 30775420 DOI: 10.15326/jcopdf.6.1.2017.0187] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
127 Greulich T, Rodríguez-Frias F, Belmonte I, Klemmer A, Vogelmeier CF, Miravitlles M. Real world evaluation of a novel lateral flow assay (AlphaKit® QuickScreen) for the detection of alpha-1-antitrypsin deficiency. Respir Res 2018;19:151. [PMID: 30103740 DOI: 10.1186/s12931-018-0826-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
128 Gatti V, Banfi P, Centanni S, D'Antonio S, Giustini S, Piraino A, Zibellini M, Marini MG. Enlightening chronic obstructive pulmonary disease through patients' and caregivers' narratives. Int J Chron Obstruct Pulmon Dis 2018;13:3095-105. [PMID: 30323580 DOI: 10.2147/COPD.S172214] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
129 Tuder RM, Petrache I. Molecular multitasking in the airspace: alpha1-antitrypsin takes on thrombin and plasmin. Am J Respir Cell Mol Biol 2007;37:130-4. [PMID: 17541009 DOI: 10.1165/rcmb.2007-0163TR] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
130 Pashandi Z, Saraygord-Afshari N, Naderi-Manesh H, Naderi M. Comparative proteomic study reveals the molecular aspects of delayed ocular symptoms induced by sulfur mustard. Int J Proteomics 2015;2015:659241. [PMID: 25685557 DOI: 10.1155/2015/659241] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
131 Hernández Pérez JM, Blanco I, Jesús Sánchez Medina A, Díaz Hernández L, Antonio Pérez Pérez J. Serum Levels of Glutamate-Pyruvate Transaminase, Glutamate-Oxaloacetate Transaminase and Gamma-Glutamyl Transferase in 1494 Patients with Various Genotypes for the Alpha-1 Antitrypsin Gene. J Clin Med 2020;9:E3923. [PMID: 33287251 DOI: 10.3390/jcm9123923] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
132 Greulich T, Vogelmeier CF. Alpha-1-antitrypsin deficiency: increasing awareness and improving diagnosis. Ther Adv Respir Dis 2016;10:72-84. [PMID: 26341117 DOI: 10.1177/1753465815602162] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 4.4] [Reference Citation Analysis]
133 Karadagi A, Johansson H, Zemack H, Salipalli S, Mörk LM, Kannisto K, Jorns C, Gramignoli R, Strom S, Stokkeland K, Ericzon BG, Jonigk D, Janciauskiene S, Nowak G, Ellis ECS. Exogenous alpha 1-antitrypsin down-regulates SERPINA1 expression. PLoS One 2017;12:e0177279. [PMID: 28486562 DOI: 10.1371/journal.pone.0177279] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]